UA111536C2 - Препарат і спосіб профілактики та лікування атипового остеопорозу - Google Patents

Препарат і спосіб профілактики та лікування атипового остеопорозу

Info

Publication number
UA111536C2
UA111536C2 UAA201412408A UAA201412408A UA111536C2 UA 111536 C2 UA111536 C2 UA 111536C2 UA A201412408 A UAA201412408 A UA A201412408A UA A201412408 A UAA201412408 A UA A201412408A UA 111536 C2 UA111536 C2 UA 111536C2
Authority
UA
Ukraine
Prior art keywords
preparation
event
osteoporosis
prophylaxis
vitamins
Prior art date
Application number
UAA201412408A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Віллорій Івановіч Струков
Ольга ДЖОНС
Євгєній Ніколаєвіч Крутяков
Константін Гєннадьєвіч Єлістратов
Original Assignee
Общєство С Огранічєнной Отвєтствєнностью "Парафарм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общєство С Огранічєнной Отвєтствєнностью "Парафарм" filed Critical Общєство С Огранічєнной Отвєтствєнностью "Парафарм"
Publication of UA111536C2 publication Critical patent/UA111536C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
UAA201412408A 2012-04-19 2012-08-21 Препарат і спосіб профілактики та лікування атипового остеопорозу UA111536C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (1)

Publication Number Publication Date
UA111536C2 true UA111536C2 (uk) 2016-05-10

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201412408A UA111536C2 (uk) 2012-04-19 2012-08-21 Препарат і спосіб профілактики та лікування атипового остеопорозу

Country Status (17)

Country Link
US (1) US9827273B2 (enExample)
EP (1) EP2845598B1 (enExample)
JP (1) JP6286417B2 (enExample)
CN (1) CN104736161B (enExample)
AU (1) AU2012377476B2 (enExample)
BR (1) BR112014025990B1 (enExample)
CA (1) CA2870823C (enExample)
DK (1) DK2845598T3 (enExample)
EA (1) EA026533B1 (enExample)
ES (1) ES2616035T3 (enExample)
IL (1) IL235169B (enExample)
IN (1) IN2014DN09780A (enExample)
LT (1) LT2845598T (enExample)
PL (1) PL2845598T3 (enExample)
RU (1) RU2497533C1 (enExample)
UA (1) UA111536C2 (enExample)
WO (1) WO2013157982A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co., Ltd. Cooking apparatus and control method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
WO2005028678A2 (en) * 2003-06-06 2005-03-31 Wyeth Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby
JP5509504B2 (ja) * 2008-02-13 2014-06-04 ディーエスエム アイピー アセッツ ビー.ブイ. 骨塩密度を改善し、骨粗鬆症を治療するための25−ヒドロキシ−ビタミンd3とビタミンd3の併用
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
AU2012377476B2 (en) 2017-10-05
BR112014025990A2 (pt) 2017-06-27
DK2845598T3 (en) 2017-04-10
AU2012377476A1 (en) 2014-12-11
AU2012377476A8 (en) 2014-12-18
CN104736161A (zh) 2015-06-24
CA2870823C (en) 2017-10-03
CN104736161B (zh) 2021-07-06
PL2845598T3 (pl) 2017-07-31
CA2870823A1 (en) 2013-10-24
RU2497533C1 (ru) 2013-11-10
JP2015516974A (ja) 2015-06-18
IN2014DN09780A (enExample) 2015-07-31
EP2845598A1 (en) 2015-03-11
US20150224150A1 (en) 2015-08-13
US9827273B2 (en) 2017-11-28
IL235169B (en) 2019-10-31
BR112014025990B1 (pt) 2021-02-17
IL235169A0 (en) 2014-12-31
EA026533B1 (ru) 2017-04-28
EP2845598A4 (en) 2015-10-28
EA201401155A1 (ru) 2015-05-29
ES2616035T3 (es) 2017-06-09
WO2013157982A1 (ru) 2013-10-24
JP6286417B2 (ja) 2018-02-28
EP2845598B1 (en) 2017-01-04
LT2845598T (lt) 2017-02-27

Similar Documents

Publication Publication Date Title
IN2014DN09780A (enExample)
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
BR112014003414A2 (pt) método de produção de níveis fisiológicos e terapêuticos de óxido nítrico através de um sistema de entrega oral
WO2010008976A3 (en) Combined calcium, magnesium and vitamin d supplements
NZ700824A (en) Use of lysosomal acid lipase for treating lysosomal acid lipase deficiency in patients
MX2012002681A (es) Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades.
IN2014DN09779A (enExample)
MX2013003523A (es) Composicion farmaceutica de dosis baja.
ES2690219T3 (es) Método para rellenar formaciones de cavidad ósea con calcio
NZ613264A (en) Use of vitamin k for weight maintenance and weight control
Maksimyuk et al. Strontium ranelate in treatment of postmenopausal osteoporosis
UA85494C2 (ru) Фармацевтическая композиция для лечения заболеваний костной ткани
Vendrell Cerebrovascular accident with haemorrhagic transformation: case report
UA58233U (ru) Способ лечения тяжелой формы эпидемического паротита у взрослых
US20190381072A1 (en) Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
UA85160U (uk) Спосіб лікування гострого атрофічного кандидозу слизової оболонки порожнини рота у хворих на цукровий діабет
NZ619215B2 (en) Method for filling bone cavities with calcium
PL413857A1 (pl) Kompozycja farmaceutyczna zawierająca połączenie witaminy D3 i K2 oraz jej zastosowanie